COMMUNIQUÉS West-GlobeNewswire

KFSH Advances Precision Surgery Through In-House 3D Printing Program
25/04/2026
RIYADH, Saudi Arabia, April 25, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is redefining surgical precision through an advanced in-house 3D printing program that is reshaping how [...]
Alpha Labs Male Enhancement Gummies Claims Evaluated: The AlphaLabs ED Gummy for Men Under Investigation
25/04/2026
A 2026 informational overview of Alpha Labs Male Enhancement Gummies covering ingredient research context, how the brand presents its men's vitality formula, pricing details, and key considerations for men exploring ED [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/04/2026
NOVATO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work
24/04/2026
A 2026 overview of Performance Lab supplements including Mind Lab Pro®, NutriGenesis® Multi, Omega-3, Sleep, Energy, and Vision — covering formulation standards, ingredient research context, third-party certifications, [...]
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
24/04/2026
Sanofi place 2,3 milliard d’euros d’emprunts obligataires Paris, 24 avril 2026 - Sanofi annonce avoir placé avec succès une émission obligataire en 3 tranches (les « obligations ») pour un montant de 2,3 milliards d’ [...]
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
24/04/2026
Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reduction Trial to adjudicate Anaptys’ contract claims and right to seek reversion of Jemperli against Tesaro/GSK is [...]
Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026
24/04/2026
World’s first Phase 3 readout for an in vivo CRISPR gene editing candidate Company to host webcast to discuss data at 8:00 a.m. ET on April 27, 2026 CAMBRIDGE, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Intellia [...]
Press Release: Sanofi successfully prices 2.3 billion of bond issue
24/04/2026
Sanofi successfully prices 2.3 billion of bond issue Paris, April 24, 2026 - Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches: €1,000 million fixed-rate notes, due [...]
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
24/04/2026
Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing [...]
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
24/04/2026
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- President [...]
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
24/04/2026
MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended March 31 [...]
Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
24/04/2026
Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache relief NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Plopii , a Brooklyn-based biotechnology [...]
Crescent Biopharma Announces Grants of Inducement Awards
24/04/2026
WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026
24/04/2026
Healthcare products company unveils new brand identity and introduces Silkura, a revolutionary silicone-based ostomy pouch BERLIN, April 24, 2026 (GLOBE NEWSWIRE) -- ForLife Produktions- und Vertriebsgesellschaft für [...]
AEON Biopharma Sets Annual Shareholder Meeting
24/04/2026
- Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical [...]
Financière de Tubize - Dividend approval
24/04/2026
Dividend confirmation Regulated information - 24 April 2026 The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a gross dividend of € [...]
Financière de Tubize - Approbation du dividende
24/04/2026
Approbation du dividende Information réglementée - 24 avril 2026 L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2025, en ce [...]
KFSH Scales Genomic Medicine from Research to Clinical Decision-Making
24/04/2026
RIYADH, Saudi Arabia, April 24, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing a clinically integrated model of genomic medicine, demonstrating how large-scale genetic [...]
Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops
24/04/2026
Metabo Drops 2026 New tasteless liquid drops designed to support weight loss by turning any coffee into a metabolism-boosting drink for enhanced fat burning, energy support, and easier daily routine with consistent use [...]

Pages